Metabolic Syndrome Linked To Parkinson's Disease, Study Says
By Dennis Thompson HealthDay Reporter

THURSDAY, Aug. 21, 2025 — Folks with metabolic syndrome have up to a 40% higher risk of developing Parkinson’s disease, a new study says.
Metabolic syndrome is a cluster of health problems that include excess belly fat, high blood pressure, elevated blood sugar and abnormal cholesterol levels.
It’s already known to increase people’s risk of heart disease, stroke and type 2 diabetes.
And now researchers have found an association between metabolic syndrome and Parkinson’s, a degenerative nerve disease that primarily affects motor skills, according to findings published Aug. 20 in the journal Neurology.
“Parkinson’s disease is the second most common neurodegenerative disorder among older adults after Alzheimer’s disease, and metabolic syndrome affects an estimated 1 in 4 adults and is highly modifiable,” researcher Weili Xu, a professor in geriatric epidemiology at the Karolinska Institute in Stockholm, said in a news release.
“Our findings suggest that metabolic syndrome may be a modifiable risk factor for Parkinson’s disease,” Xu said.
For the study, researchers analyzed data for more than 467,000 participants in the UK Biobank, a large-scale health research project in the United Kingdom. Nearly 2 of 5 people (38%) had metabolic syndrome.
Participants were followed for a median of 15 years, during which more than 3,200 developed Parkinson’s disease. Median means half were followed longer, half for a shorter time.
People with metabolic syndrome were about 40% more likely to develop Parkinson’s than those without the syndrome, results show.
Researchers also pooled their research with data gathered in eight previous studies, creating a group of nearly 25 million people with more than 98,500 cases of Parkinsons.
In that meta-analysis, the team found a 29% increased risk of Parkinson’s among people with metabolic syndrome.
“We also found a higher risk of Parkinson’s disease for people with both metabolic syndrome and a genetic susceptibility for Parkinson’s disease,” Xu said. “This suggests that maintaining metabolic health may be especially important for people who have genes that increase their risk for Parkinson’s disease.”
Parkinson’s occurs when the body’s ability to produce the neurochemical dopamine is damaged or destroyed. A lack of dopamine causes the movement problems associated with the disease.
Researchers said the health problems associated with metabolic syndrome might impair dopamine production in the body. High blood pressure and high cholesterol also might damage the tiny blood vessels in the brain, contributing to Parkinson’s.
Researchers noted that their findings could not prove a direct cause-and-effect link between metabolic syndrome and Parkinson’s, only an association.
“Future studies are needed to see whether working to control metabolic syndrome could help prevent Parkinson’s disease,” Xu concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-22 00:00
Read more

- Cardiac Arrest Can Happen Suddenly — Here's Everything You Need to Know
- Less Processed Diet May Be More Beneficial for Weight Loss
- High Noon Recalls Vodka Seltzer Cans Mislabeled as Energy Drinks
- Stealth Biotherapeutics Resubmits New Drug Application for Elamipretide for the Treatment of Barth Syndrome
- Tamiflu Safe For Children, Study Concludes
- AMA, AAP, IDSA Among Organizations Disinvited From CDC Vaccine Workgroups
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions